In this analysis, researchers aimed to evaluate the clinicopathologic characteristics, metastatic patterns, and survival outcomes in patients with metastatic prostate cancer and low-volume primary ...
Advanced prostate cancer cases are rising worldwide as fewer men undergo routine PSA screening and early symptoms go ...
Researchers at VCU Massey Comprehensive Cancer Center and the VCU Institute of Molecular Medicine (VIMM) were recently ...
Advanced imaging, particularly PSMA PET scans, enhances detection of microscopic disease, allowing for more precise treatment ...
In May 2025, Joe Biden's office announced that he had been diagnosed with an aggressive form of prostate cancer that had ...
MELBOURNE, Australia and INDIANAPOLIS, Jan. 20, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, ...
Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) provides an update on its commercial and operational ...
More good news from the drug developer. The post Telix shares in focus as the company meets guidance appeared first on The ...
Prostate cancer is a type of cancer that starts in the prostate gland, that helps make semen. Most men don’t notice anything ...
New recommendations prioritise multiparametric MRI, safer transperineal biopsy, and earlier escalation for high-risk prostate ...
New Scientist on MSN
Bone cancer therapy unexpectedly makes tumours less painful
A drug that kills cancer cells by puncturing them comes with an additional benefit: tests in mice suggest it reduces the growth of pain-sensing nerves around tumours ...
Why do some tumors spread while others remain localized? The mechanisms governing the metastatic potential of tumor cells ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback